Advertisement

Selenium Status in Northern Ireland and France

The Prime Study
  • Dorothy McMaster
  • Pedro Marques-Vidal
  • Pierre Ducimetière
  • Phillipe Amouyel
  • Dominique Arveiler
  • Alun Evans
Chapter
  • 22 Downloads

Keywords

Coronary Heart Disease Serum Selenium Selenium Status Classical Risk Factor Serum Fatty Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kok, F.J., de Bruijn, A.M., Vermeeren, R., Hofman, A., van Laar, A., de Bruin, M., Hermus, R.J.J., and Valkenburg, H.A., 1987, Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands, Am. J. Clin. Nutr.45:462–468.CrossRefGoogle Scholar
  2. McMaster, D., Bell, N., Anderson, P., and Love, A.H.G., 1990, Automated measurement of two indicators of human selenium status, and applicability to population studies, Clin Chem.36:211–216.CrossRefGoogle Scholar
  3. Miettinen, T.A., Alfthan, G., Huttunen, J.K., Pikkarainen, J., Naukkarinen, V., Mattila, S., and Kumlin, T., 1987, Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids, BMJ. 287:517–519.CrossRefGoogle Scholar
  4. Ringstad, J., Jacobsen, B.K., and Thomassen, Y., 1987, The Tromsø Heart Study: Relationships between the concentration of selenium in serum and risk factors for coronary heart disease, J. Trace Elem. Electrolytes Health Dis. 1:27–31.PubMedGoogle Scholar
  5. Robinson, M.F., Campbell, D.R., Sutherland, W.H.F., Herbison, G.P., Paulin, J.M., and Simpson, F.O., 1983, Selenium and risk factors for CHD in New Zealand, NZ. Med. J.96:755–757.Google Scholar
  6. Salonen, J.T., Alfthan, G., Huttunen, J.K., Pikkarainen, J., and Puska, P., 1982, Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study, Lancet1982:175.CrossRefGoogle Scholar
  7. Salonen, J.T., Salonen, R., Penttilä, I., Herranen, J., Jauhaiainen, M., Kantola, M., Lappeteläinen, M.S., Mäenpää, P.H., Alfthan, G., and Puska, P., 1985, Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease, Am. J. Cardiol.56:226–231.CrossRefGoogle Scholar
  8. Salvini, S., Hennekens, C.H., Morris, J.S., Willett, W.C., and Stampfer, M.J., 1995, Plasma levels of the antioxidant selenium and risk of myocardial infarctionamong U.S. Physicians, Am. J. Cardiol.76:1218–1221.CrossRefGoogle Scholar
  9. Suadicani, P., Hein, H.O., and Gyntelberg, F., 1992, Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3,000 males, Atherosclerosis, 96:33–42.CrossRefGoogle Scholar
  10. The PRIME Study Group (prepared by JWG Yarnell), 1998, The PRIME Study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland, Q. J. Med.91:667–676.CrossRefGoogle Scholar
  11. Tunstall-Pedoe, H. et al. On behalf of WHO MONICA Project., 1994, Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation; 90:583–612.CrossRefGoogle Scholar
  12. van‐t Veer, P. and Alfthan, G., 1991, Biomarkers of Se, workshop report, in: Biomarkers of Dietary Exposure, (F.J. Kok, P. van’t Veer, eds.). Proceedings of the 3rd meeting on Nutritional Epidemiology, pp. 106–118, Smith Gordon and Company Ltd., London.Google Scholar
  13. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J.K., and Karvonen, M.J., 1985, Serum selenium and the risk of coronary heart disease and stroke, Am. J. Epidemiol.122:276–281.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Dorothy McMaster
    • 1
    • 2
  • Pedro Marques-Vidal
    • 3
  • Pierre Ducimetière
    • 4
  • Phillipe Amouyel
    • 5
  • Dominique Arveiler
    • 6
  • Alun Evans
    • 2
  1. 1.Department of MedicineInstitute of Clinical ScienceBelfastNorthern Ireland
  2. 2.The Queen’s University of BelfastBelfastNorthern Ireland
  3. 3.INSERM CJF 94-06ToulouseFrance
  4. 4.Coordinating CentreU258 INSERMParisFrance
  5. 5.INSERM CJF 95-05Institut Pasteur-LilleFrance
  6. 6.Laboratoire’ Epidémiologie et de Santé PubliqueStrasbourgFrance

Personalised recommendations